Medtronic's ATS acquisition
This article was originally published in The Gray Sheet
Executive Summary
Transaction is expected to close "on or about Aug. 12" following shareholder approval of the $370 million deal, ATS Medical reports Aug. 5. Medtronic announced plans to acquire ATS April 29 (1"The Gray Sheet" May 3, 2010)
You may also be interested in...
Medtronic Shores Up Tissue Valve Portfolio With ATS Medical Acquisition
Medtronic will expand its pericardial tissue heart valve offerings and further strengthen its cardiovascular business through its $370 million acquisition of ATS Medical, announced April 29
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.